{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:15:23Z","timestamp":1787915723881,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11606-025-09680-7","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:01:45Z","timestamp":1751889705000},"page":"521-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cMedical Cannabis\u201d: Advising Patients While Navigating Medical Ethics and Limited Evidence"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3582-3506","authenticated-orcid":false,"given":"Anna-Maria","family":"South","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna L.","family":"Babalonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Fanucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"9680_CR1","unstructured":"American Society of Addiction Medicine. Public policy statement on cannabis. Available at https:\/\/www.asam.org\/docs\/default-source\/public-policy-statements\/2020-public-policy-statement-on-cannabis.pdf?sfvrsn=aa3c58c2_2 Accessed on\u00a010  Feb 2023."},{"key":"9680_CR2","doi-asserted-by":"crossref","unstructured":"Freckelton I. Children as voices and images for medicinal cannabis law reform. Monash Bioeth Rev. 2021;39: 4\u201325.","DOI":"10.1007\/s40592-021-00139-z"},{"key":"9680_CR3","unstructured":"Team Kentucky Office of Medical Cannabis. Kentucky medical cannabis program regulations. Available at https:\/\/kymedcan.ky.gov\/laws-and-regulations\/Pages\/Regulations.aspx. Accessed on 8 Oct 2024."},{"key":"9680_CR4","unstructured":"United States Drug Enforcement Administration. Drug scheduling. Available at https:\/\/www.dea.gov\/drug-information\/drug-scheduling. Accessed on 8 Oct 2024."},{"key":"9680_CR5","unstructured":"Food and Drug Enforcement Administration. Full prescribing information. Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/018651s029lbl.pdf. Accessed on 17 Feb 2025."},{"key":"9680_CR6","unstructured":"Food and Drug Enforcement Administration. FDA approves new indication for drug containing an active ingredient derived from cannabis to treat seizures in rare genetic disease. Available at https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-indication-drug-containing-active-ingredient-derived-cannabis-treat-seizures-rare Accessed on 17 Feb 2025."},{"issue":"10","key":"9680_CR7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005.Erratum.In:JAMAInternMed.2014Nov;174(11):1875.PMID:25154332;PMCID:PMC4392651","volume":"174","author":"MA Bachhuber","year":"2014","unstructured":"Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668-73. https:\/\/doi.org\/10.1001\/jamainternmed.2014.4005. Erratum in: JAMA Intern Med. 2014;174(11):1875.","journal-title":"JAMA Intern Med."},{"issue":"26","key":"9680_CR8","doi-asserted-by":"publisher","first-page":"12624","DOI":"10.1073\/pnas.1903434116","volume":"116","author":"CL Shover","year":"2019","unstructured":"Shover CL, Davis, CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci U S A. 2019;116(26):12624-12626. https:\/\/doi.org\/10.1073\/pnas.1903434116","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9680_CR9","doi-asserted-by":"publisher","unstructured":"Myran\u00a0DT\ufeff, Pugliese M\ufeff, McDonald AJ\ufeff, et al. Cannabis use disorder emergency department visits and hospitalizations and 5-year mortality.\u00a0\ufeff JAMA Netw Open. 2025;8(2):e2457852. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.57852","DOI":"10.1001\/jamanetworkopen.2024.57852"},{"key":"9680_CR10","doi-asserted-by":"publisher","unstructured":"McGinty EE, Tormohlen KN, Seewald NJ et al. Effects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain. Annals of Internal Medicine. 2023;176(7):904\u2013912. https:\/\/doi.org\/10.7326\/M23-0053","DOI":"10.7326\/M23-0053"},{"issue":"7","key":"9680_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States. Biol Psychiatry. 2016;79(7):613\u2013619. https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.004","journal-title":"Biological Psychiatry."},{"key":"9680_CR12","unstructured":"Stuyt E. The problem with the current high potency THC Marijuana from the perspective of an addiction psychiatrist. Mo Med. 2018;115(6):482\u2013486.\u00a0"},{"key":"9680_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055821","volume":"8","author":"A Batalla","year":"2013","unstructured":"Batalla A, Bhattacharyya S, Y\u00fccel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One. 2013;8:e55821","journal-title":"PLoS One."},{"key":"9680_CR14","unstructured":"National Institute on Drug Abuse. Reported drug use among adolescents continued to hold below pre-pandemic levels in 2023. https:\/\/nida.nih.gov\/news-events\/news-releases\/2023\/12\/reported-drug-use-among-adolescents-continued-to-hold-below-pre-pandemic-levels-in-2023 Accessed on 10 Feb 2024."},{"key":"9680_CR15","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0863","author":"CJ Maxwell","year":"2020","unstructured":"Maxwell CJ, Jesdale BM and Lapane KL. Recent trends in cannabis use in older americans. Ann Intern Med. 2020. https:\/\/doi.org\/10.7326\/M20-0863","journal-title":"Annals of Internal Medicine."},{"issue":"9","key":"9680_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1017\/S1041610217002794","volume":"30","author":"NG Choi","year":"2018","unstructured":"Choi NG, DiNitto DM, Marti CN. Older marijuana users\u2019 marijuana risk perceptions: associations with marijuana use patterns and marijuana and other substance use disorders.\u00a0Int Psychogeriatr. 2018;30(9):1311-1322. https:\/\/doi.org\/10.1017\/S1041610217002794","journal-title":"International Psychogeriatrics."},{"key":"9680_CR17","doi-asserted-by":"publisher","unstructured":"Martins SS, Mauro CM, Santaella-Tenorio J et al. State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug Alcohol Depend. 2016;169:26\u201332. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.10.004","DOI":"10.1016\/j.drugalcdep.2016.10.004"},{"key":"9680_CR18","doi-asserted-by":"publisher","unstructured":"Hoch E, Volkow ND, Friemel CM, Lorenzetti V, Freeman TP, Hall W. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur Arch Psychiatry Clin Neurosci. 2025;275(2):281\u2013292. https:\/\/doi.org\/10.1007\/s00406-024-01880-2. Epub 2024 Sep 19.\u00a0","DOI":"10.1007\/s00406-024-01880-2"},{"issue":"24","key":"9680_CR19","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/NEJMra2212152","volume":"389","author":"DA Gorelick","year":"2023","unstructured":"Gorelick DA. Cannabis-Related Disorders and Toxic Effects. N Engl J Med. 2023;389(24):2267-2275. https:\/\/doi.org\/10.1056\/NEJMra2212152.\u00a0","journal-title":"N Engl J Med."},{"issue":"1","key":"9680_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s42238-024-00215-1.PMID:38308382;PMCID:PMC10837858","volume":"6","author":"A Brooks-Russell","year":"2024","unstructured":"Brooks-Russell A, Wrobel J, Brown T, et al. Effects of acute cannabis inhalation on reaction time, decision-making, and memory using a tablet-based application. J Cannabis Res. 2024;6(1):3. https:\/\/doi.org\/10.1186\/s42238-024-00215-1.\u00a0","journal-title":"J Cannabis Res."},{"issue":"3","key":"9680_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/08897077.2020.1784359","volume":"42","author":"M Levine","year":"2021","unstructured":"Levine M, Jontz A, Dabrowski P et al. Prevalence of marijuana use among trauma patients before and after legalization of medical marijuana: The Arizona experience. Subst Abus. 2021;42(3):366-371. https:\/\/doi.org\/10.1080\/08897077.2020.1784359. Epub 2020 Jul 21.\u00a0","journal-title":"Subst Abus."},{"key":"9680_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1513\/AnnalsATS.201212-127FR","volume":"10","author":"DP Tashkin","year":"2013","unstructured":"Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10:239-247.","journal-title":"Ann Am Thorac Soc."},{"issue":"9","key":"9680_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamasurg.2023.2403","volume":"158","author":"PP Potnuru","year":"2023","unstructured":"Potnuru PP, Jonna S, Williams GW. Cannabis use disorder and perioperative complications. JAMA Surg. 2023;158(9):935\u2013944. https:\/\/doi.org\/10.1001\/jamasurg.2023.2403","journal-title":"JAMA Surg."},{"key":"9680_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/rapm-2022-104013","volume":"48","author":"S Shah","year":"2023","unstructured":"Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med 2023;48:97-117.","journal-title":"Regional Anesthesia & Pain Medicine"},{"issue":"14","key":"9680_CR25","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.2024.2075","volume":"331","author":"S Anderer","year":"2024","unstructured":"Anderer S. Cannabis use linked to elevated myocardial infarction and stroke risk. JAMA. 2024;331(14):1172. https:\/\/doi.org\/10.1001\/jama.2024.2075","journal-title":"JAMA."},{"issue":"9","key":"9680_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.31937","volume":"5","author":"DT Myran","year":"2022","unstructured":"Myran DT, Roberts R, Pugliese M, Taljaard M, Tanuseputro P, Pacula RL. Changes in emergency department visits for cannabis hyperemesis syndrome following recreational cannabis legalization and subsequent commercialization in Ontario, Canada. JAMA Netw Open. 2022;5(9):e2231937. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.31937","journal-title":"JAMA Netw Open."},{"key":"9680_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-022-00918-y","volume":"7","author":"X Xiong","year":"2022","unstructured":"Xiong X, Chen S, Shen J et al. Cannabis suppresses antitumor immunity by inhibiting JAK\/STAT signaling in T cells through CNR2. Sig Transduct Target Ther. 2022;7:99. https:\/\/doi.org\/10.1038\/s41392-022-00918-y","journal-title":"Sig Transduct Target Ther."},{"key":"9680_CR28","doi-asserted-by":"crossref","unstructured":"Biedny A, Szpunar S, Abdalla A, Kafri Z, Hadid TH. The effect of concomitant cannabinoids during immune checkpoint inhibitor treatment of advanced stage malignancy. J Clin Oncol. 2020;38(15).","DOI":"10.1200\/JCO.2020.38.15_suppl.e15064"},{"key":"9680_CR29","doi-asserted-by":"publisher","unstructured":"Taha T, Meiri D, Talhamy S, Wollner M, Peer A, Bar-Sela G. Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies. Oncologist. 2019;24(4):549\u2013554. https:\/\/doi.org\/10.1634\/theoncologist.2018-0383. Epub 2019 Jan 22.\u00a0","DOI":"10.1634\/theoncologist.2018-0383"},{"issue":"9","key":"9680_CR30","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/cancers12092447.Erratum.In:Cancers(Basel).2022Apr13;14(8):PMID:32872248;PMCID:PMC7563978","volume":"12","author":"G Bar-Sela","year":"2020","unstructured":"Bar-Sela G, Cohen I, Campisi-Pinto S et al. Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome. Cancers (Basel). 2020;12(9):2447. https:\/\/doi.org\/10.3390\/cancers12092447. Erratum in: Cancers (Basel). 2022 Apr 13;14(8).","journal-title":"Cancers (Basel)."},{"key":"9680_CR31","doi-asserted-by":"crossref","unstructured":"Sarsembayeva A, Schicho R. Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful? Frontiers in Oncology. 2023;13.","DOI":"10.3389\/fonc.2023.1296906"},{"key":"9680_CR32","doi-asserted-by":"publisher","unstructured":"Nielsen S, Picco L, Murnion B et al. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies. Neuropsychopharmacol. 2022;47(7):1315\u20131330. https:\/\/doi.org\/10.1038\/s41386-022-01322-4. Epub 2022 Apr 22.\u00a0","DOI":"10.1038\/s41386-022-01322-4"},{"issue":"11","key":"9680_CR33","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00213-019-05293-1","volume":"236","author":"S Babalonis","year":"2019","unstructured":"Babalonis S, Lofwall MR, Sloan PA, Nuzzo PA, Fanucchi LC, Walsh SL. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans. Psychopharmacology. 2019;236(11):3341\u20133352. https:\/\/doi.org\/10.1007\/s00213-019-05293-1","journal-title":"Psychopharmacology."},{"key":"9680_CR34","doi-asserted-by":"crossref","unstructured":"Cooper ZD. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacol. 2018;43(10).","DOI":"10.1038\/s41386-018-0011-2"},{"key":"9680_CR35","doi-asserted-by":"crossref","unstructured":"Dunn KE, Bergeria CL, Huhn AS et al. Within-subject, double-blinded, randomized, and placebo-controlled eval. of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model. Neuropsychopharm 2021;46(8):1451\u20131459.","DOI":"10.1038\/s41386-021-01007-4"},{"issue":"11","key":"9680_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.571832.PMID:33013414;PMCID:PMC7516211","volume":"11","author":"Z Montoya","year":"2020","unstructured":"Montoya Z, Conroy M, Vanden Heuvel BD, Pauli CS, Park SH. Cannabis contaminants limit pharmacological use of cannabidiol. Front Pharmacol. 2020;11:571832. https:\/\/doi.org\/10.3389\/fphar.2020.571832.\u00a0","journal-title":"Front Pharmacol."},{"key":"9680_CR37","doi-asserted-by":"crossref","unstructured":"Seltenrich N. Cannabis contaminants: regulating solvents, metals and microbes in legal weed. Environ Health Perspect. 2019;127(8).","DOI":"10.1289\/EHP5785"},{"key":"9680_CR38","unstructured":"Evans, David G. Medical fraud, mislabeling, contamination: all common in CBD products. Mo Med. 2020;117(5):394\u2013399. Print."},{"issue":"4","key":"9680_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajog.2025.01.007","volume":"232","author":"LL Habersham","year":"2025","unstructured":"Habersham LL, Townsel C, Terplan M, Hurd YL. Substance use and substance use disorders during pregnancy and the postpartum period. Am J Obstet Gynecol. 2025;232(4):337-353.","journal-title":"American Journal of Obstetrics and Gynecology."},{"issue":"6","key":"9680_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/AOG.0000000000002619.PMID:29742676;PMCID:PMC5970054","volume":"131","author":"B Dickson","year":"2018","unstructured":"Dickson B, Mansfield C, Guiahi M et al. Recommendations from cannabis dispensaries about first-trimester cannabis use. Obstet Gynecol. 2018;131(6):1031-1038. https:\/\/doi.org\/10.1097\/AOG.0000000000002619.\u00a0","journal-title":"Obstet Gynecol."},{"key":"9680_CR41","doi-asserted-by":"crossref","unstructured":"Wakefield T, Bialous S, Apollonio DE. Clearing cannabis criminal records: a survey of criminal record expungement availability and accessibility among US States and Washington DC that decriminalized or legalized cannabis. Int J Drug Policy. 2023;114:103983\u2013103983. Web.","DOI":"10.1016\/j.drugpo.2023.103983"},{"key":"9680_CR42","unstructured":"American Civil Liberties Union. Report: the war on marijuana in black and white. https:\/\/www.aclu.org\/report\/report-war-marijuana-black-and-white. Accessed on\u00a028 Aug 2023."},{"key":"9680_CR43","unstructured":"American Society of Addiction Medicine. Public policy statement on cannabis. Available at https:\/\/www.asam.org\/docs\/ Accessed on 1 April 2025."},{"issue":"6","key":"9680_CR44","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","volume":"173","author":"DS Hasin","year":"2016","unstructured":"Hasin DS, Kerridge BT, Saha TD et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions\u2013III. Am J Psychiatry. 2016;173(6):588\u2013599. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15070907","journal-title":"The American Journal of Psychiatry."},{"issue":"2","key":"9680_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281826.PMID:36800328;PMCID:PMC9937508","volume":"18","author":"D Wolfe","year":"2023","unstructured":"Wolfe D, Corace K, Butler C et al. Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature. PLoS One. 2023 Feb 17;18(2):e0281826. https:\/\/doi.org\/10.1371\/journal.pone.0281826.\u00a0","journal-title":"PLoS One."},{"issue":"6","key":"9680_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/ADM.0000000000001338","volume":"18","author":"Y-L Tang","year":"2024","unstructured":"Tang Y-L, McCord E, Earley PH, Drexler K. Addressing confusion and inconsistencies surrounding the provider role in medical cannabis programs. J Addict Med. 2024;18(6):611-613. https:\/\/doi.org\/10.1097\/ADM.0000000000001338","journal-title":"Journal of Addiction Medicine."},{"key":"9680_CR47","unstructured":"History. When cigarette companies used doctors to push smoking. Available at https:\/\/www.history.com\/news\/cigarette-ads-doctors-smoking-endorsement Accessed on 10 Feb 2023."},{"issue":"2","key":"9680_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2013.285112","volume":"311","author":"TR Holford","year":"2014","unstructured":"Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311(2):164\u2013171. https:\/\/doi.org\/10.1001\/jama.2013.285112","journal-title":"JAMA."},{"key":"9680_CR49","unstructured":"Gale AH. Drug company compensated physicians role in causing america\u2019s deadly opioid epidemic: when will we learn? Mo Med. 2016;113(4):244\u2013246.\u00a0"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09680-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:05:05Z","timestamp":1783375505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9680"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09680-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate:"}},{"value":"MRL has been a scientific consultant in the last three years (unrelated to this paper) for Berkshire Biomedical, Braeburn, Camurus, and Journey Colab. SB has previously been a scientific consultant to Canopy Growth Corporation (unrelated to this paper). The other authors report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}